Clinical Trial Update: A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating continuous infusions of HNO (Nitroxyl) donor in patients with heart failure and reduced ejection fraction; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Reduced Ventricular Ejection Fraction

Drugs mentioned

• HNO donor (Nitroxyl donor) (Nitroxyl donor)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Heart Failure, Cardiac Failure | Phase 2 | Status: COMPLETED | Results posted: 2020-07-27